Annual Cash & Cash Equivalents
$84.38 M
-$72.64 M-46.26%
December 31, 2024
Summary
- As of March 10, 2025, IDYA annual cash & cash equivalents is $84.38 million, with the most recent change of -$72.64 million (-46.26%) on December 31, 2024.
- During the last 3 years, IDYA annual cash & cash equivalents has fallen by -$7.67 million (-8.33%).
- IDYA annual cash & cash equivalents is now -46.26% below its all-time high of $157.02 million, reached on December 31, 2023.
Performance
IDYA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$84.38 M
-$315.90 M-78.92%
December 31, 2024
Summary
- As of March 10, 2025, IDYA quarterly cash and cash equivalents is $84.38 million, with the most recent change of -$315.90 million (-78.92%) on December 31, 2024.
- Over the past year, IDYA quarterly cash and cash equivalents has dropped by -$23.97 million (-22.12%).
- IDYA quarterly cash and cash equivalents is now -78.92% below its all-time high of $400.28 million, reached on September 30, 2024.
Performance
IDYA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IDYA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.3% | -22.1% |
| 3 y3 years | -8.3% | -22.1% |
| 5 y5 years | +147.7% | -22.1% |
IDYA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.3% | +22.9% | -78.9% | +71.8% |
| 5 y | 5-year | -46.3% | +147.7% | -78.9% | +147.7% |
| alltime | all time | -46.3% | +1315.5% | -78.9% | +311.5% |
IDEAYA Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $84.38 M(-46.3%) | $84.38 M(-78.9%) |
| Sep 2024 | - | $400.28 M(+118.7%) |
| Jun 2024 | - | $183.05 M(+69.0%) |
| Mar 2024 | - | $108.34 M(-31.0%) |
| Dec 2023 | $157.02 M(+128.8%) | $157.02 M(+3.4%) |
| Sep 2023 | - | $151.85 M(+47.7%) |
| Jun 2023 | - | $102.84 M(+53.0%) |
| Mar 2023 | - | $67.24 M(-2.0%) |
| Dec 2022 | $68.63 M(-25.4%) | $68.63 M(-32.7%) |
| Sep 2022 | - | $101.95 M(+107.6%) |
| Jun 2022 | - | $49.11 M(-11.2%) |
| Mar 2022 | - | $55.29 M(-39.9%) |
| Dec 2021 | $92.05 M | $92.05 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $108.43 M(+19.9%) |
| Jun 2021 | - | $90.43 M(-33.9%) |
| Mar 2021 | - | $136.75 M(+89.8%) |
| Dec 2020 | $72.04 M(+111.5%) | $72.04 M(-11.3%) |
| Sep 2020 | - | $81.24 M(-44.9%) |
| Jun 2020 | - | $147.54 M(+316.1%) |
| Mar 2020 | - | $35.46 M(+4.1%) |
| Dec 2019 | $34.07 M(+66.1%) | $34.07 M(-12.3%) |
| Sep 2019 | - | $38.85 M(-55.9%) |
| Jun 2019 | - | $88.11 M(+149.6%) |
| Mar 2019 | - | $35.30 M(+72.2%) |
| Dec 2018 | $20.50 M(+244.0%) | $20.50 M |
| Dec 2017 | $5.96 M | - |
FAQ
- What is IDEAYA Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual cash & cash equivalents year-on-year change?
- What is IDEAYA Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly cash and cash equivalents year-on-year change?
What is IDEAYA Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of IDYA is $84.38 M
What is the all time high annual cash & cash equivalents for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual cash & cash equivalents is $157.02 M
What is IDEAYA Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, IDYA annual cash & cash equivalents has changed by -$72.64 M (-46.26%)
What is IDEAYA Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IDYA is $84.38 M
What is the all time high quarterly cash and cash equivalents for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly cash and cash equivalents is $400.28 M
What is IDEAYA Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, IDYA quarterly cash and cash equivalents has changed by -$23.97 M (-22.12%)